{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie6t6xwtmf67r62ekeeiioye47h6k3jm6zlpqs6uvnbpdetatpgzq",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mn6ax7i5ofy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid42nrkdbfyjgb7irw7sy3po6pcdfyh7mq3tcr262kmf77s3m4et4"
    },
    "mimeType": "image/jpeg",
    "size": 1871
  },
  "path": "/story/390139/pancreatic-cancer-trial-shows-pill-doubling-survival-rates.html",
  "publishedAt": "2026-05-31T12:22:54.000Z",
  "site": "https://www.newser.com",
  "textContent": "A pill that's been in the works since the Carter administration has changed the math on one of the deadliest cancers. In a study of 500 people with advanced pancreatic cancer whose disease had already worsened after one round of treatment, those who took the experimental drug daraxonrasib lived a...",
  "title": "In Trial, Pill Doubles Pancreatic Cancer Survival"
}